Miro Venturi - Concepedia

Author

Miro Venturi

Max Planck Institute of Biophysics

Also Known As

M Venturi, M. Venturi, MIRO VENTURI, Miro Venturi, R. Wyatt, Venturi, M.

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Biophysics Hebrew University of Jerusalem National Institutes of Health Roche (Switzerland)Harvard University

About

Miro Venturi is an author at Max Planck Institute of Biophysics specializing in medicine, hiv, and antibody engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.9K
2	Biochemistry	5	5	1.5K
3	Natural Sciences	3	3	885
4	Engineering	2	2	116
5	Allergy	1	1	545

Miro Venturi

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Peter D. Kwong, Michael L. Doyle, David J. Casper, Nature Human RetrovirusImmunologyAntiviral ResponseMolecular BiologyVirology	2002	890
Structure of a Na+/H+ antiporter and insights into mechanism of action and regulation by pH Carola Hunte, Emanuela Screpanti, Miro Venturi, Nature Signal TransductionMolecular PhysiologyBiochemistryHyperpolarization (Biology)Natural Sciences	2005	644
The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 Rogier W. Sanders, Miro Venturi, Linnea Schiffner, Journal of Virology ImmunologyGlycobiologyNeutralizing Antibody 2G12Antigen ProcessingViral Structural Protein	2002	545
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1 Aran F. Labrijn, Pascal Poignard, Aarti Raja, Journal of Virology ImmunologyGlycobiologyMolecular BiologyViral Structural ProteinImmunotherapy	2003	353
Structural basis of tyrosine sulfation and V <sub>H</sub> -gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 Chih-chin Huang, Miro Venturi, Shahzad Majeed, Proceedings of the National Academy of Sciences	2004	265
Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120 Hyeryun Choe, Wenhui Li, Paulette L. Wright, Cell Hiv-1 Gp120BiochemistryG Protein-coupled ReceptorNatural SciencesTyrosine Sulfation	2003	225
High level production of functional antibody fab fragments in an oxidizing bacterial cytoplasm11Edited by J. Karn Miro Venturi, C. Seifert, Carola Hunte Journal of Molecular Biology High Level ProductionEngineeringProtein BiosynthesisJ. KarnBiotechnology	2002	87
Oligomerization of NhaA, the Na<sup>+</sup>/H<sup>+</sup> Antiporter of <i>Escherichia coli</i> in the Membrane and Its Functional and Structural Consequences Yoram Gerchman, Abraham Rimon, Miro Venturi, Biochemistry	2001	84
Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations Lisa Zimmer, Fabrice Barlési, Maria Martinez‐García, Clinical Cancer Research	2014	69
A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity Raffaella Castoldi, Veronika Ecker, Laura Wiehle, Oncogene	2013	61

Page 1